companydata.dkcompanydata.dk

Sapphire Bioscience Holding ApS: Financial statements 2025

CVR: 38599917

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Sapphire Bioscience Holding ApS (CVR 38599917) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -112,000 and a net result of DKK 3,266,000 compared with DKK 38,793,000 the year before. Equity in the 2025 report amounted to DKK 148,277,000. The solvency ratio was 77.6%. The company had 1 employee in the financial year.

Gross Profit
DKK -112,000
Profit/Loss
DKK 3,266,000
Equity
DKK 148,277,000
Total Assets
DKK 191,091,000
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--112 t.3.3 mio.148.3 mio.1
2024--175 t.38.8 mio.180.7 mio.1
2023--49 t.28 mio.154.3 mio.1
2022--64 t.43.7 mio.189 mio.1
2021--12 t.35.8 mio.144.3 mio.56

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Sapphire Bioscience Holding ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Gustaf Peter Reinhold von Ehrenheim joins the board of Sapphire Bioscience Holding ApSDec 3, 2025

As of December 3, 2025, Gustaf Peter Reinhold von Ehrenheim has joined the board of directors of Sapphire Bioscience Holding ApS.

Harald Høegh joins the board of Sapphire Bioscience Holding ApSDec 3, 2025

As of December 3, 2025, Harald Høegh has joined the board of directors of Sapphire Bioscience Holding ApS.

Gustaf Peter Reinhold von Ehrenheim leaves the board of Sapphire Bioscience Holding ApSDec 2, 2025

As of December 2, 2025, Gustaf Peter Reinhold von Ehrenheim has left the board of directors of Sapphire Bioscience Holding ApS.

Harald Høegh leaves the board of Sapphire Bioscience Holding ApSDec 2, 2025

As of December 2, 2025, Harald Høegh has left the board of directors of Sapphire Bioscience Holding ApS.

Michel Krall Jürgens joins Sapphire Bioscience Holding ApS as directorJul 9, 2025

As of July 9, 2025, Michel Krall Jürgens is registered as director of Sapphire Bioscience Holding ApS.

Thais Taaning Johansen steps down as director of Sapphire Bioscience Holding ApSJul 9, 2025

As of July 9, 2025, Thais Taaning Johansen has stepped down as director of Sapphire Bioscience Holding ApS.

Sapphire Bioscience Holding ApS: The 2024 annual report is outMay 9, 2025

Sapphire Bioscience Holding ApS has published its annual report for 2024. Gross profit came to DKK -175,000, and the net result was DKK 38,793,000.

About Sapphire Bioscience Holding ApS

Sapphire Bioscience Holding ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by TTJ Invest Holding ApS and Vind Industry AS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -112,000 and a net result of DKK 3,266,000 compared with DKK 38,793,000 the year before. Equity in the 2025 report amounted to DKK 148,277,000.

Source: annual report 2025, Danish Business Authority

Other financial years